Observations on Factor X Activity after Adsorption to Barium Sulphate

Summary

The amount of preformed clotting activity exhibited by factor X was found to be closely related to the bulk density of the barium sulphate used for its adsorption from serum.

The X-ray grade of barium sulphate compares closely with that manufactured by precipitation and its bulk density is half that of the soil grade which is similar to the material obtained by grinding natural barytes. Microscopically, the soil grade shows an irregular crystalline surface and when used for the adsorption of serum, the resulting eluate has a greater clotting and esterase activity than is the case when the X-ray grade, which has a smooth surface, is used. Possible mechanisms leading to the surface activation of factor X by barium sulphate are discussed and the findings are also related to earlier observations on variations in the availability of serum thrombotic accelerator (STA) after its adsorption to the same grade of barium sulphate.

The importance of defining the barium sulphate used for the adsorption of clotting factors in terms of its physical properties and microscopic appearance is emphasised.

• References

• 1 Bachmann F, Duckeet F, and Koller F. 1958; The Stuart-Prower factor and its clinical significance. Thrombosis et Diathesis Haemorrhagica 2: 24.
• 2 Barton P. G, Yin Y. T, and Wessler S. 1970; Reactions of activated factor X phosphatide mixtures in vitro and in vivo. Journal of Lipid Research 11: 87.
• 3 Bikerman J. J. 1941; Immobile layer at the solid - liquid interface. Journal of Chemical Physics 9: 880.
• 4 Brown M. E. 1960; The colorimetrie determination of arginine ester hydrolysis by human sera. Journal of Laboratory and Clinical Medicine 55: 616.
• 5 Buchanan A. S, and Heymann E. 1948; The electrokinetic potential of barium sulphate. Proceedings of the Royal Society, Series A 195: 150.
• 6 Esnouf M. P, and Williams W. J. 1962; The isolation and purification of a bovine plasma protein which is a substrate for the coagulant fraction of Russell’s viper venom. Biochemical Journal 84: 62.
• 7 Hanson S. W. F, and Olley J. 1963; Application of the Bligh and Dyer method of lipid extraction to tissue homogenates. Biochemical Journal 89: 101.
• 8 Howell R. M, and Dupe R. J. 1971; a Activation of coagulation factor X by insoluble trypsin. Biochemical Journal 123: 11.
• 9 Howell R. M, and Dupe R. J. 1971; b The role of digitonin in the activation of serum thrombotic accelerator. British Journal of Experimental Pathology 52: 495.
• 10 Howell R. M, and Scott G. B. D. 1964; The role of lipoproteins in the production of hypercoagulability: a new concept. British Journal of Experimental Pathology 45: 618.
• 11 Howell R. M, and Scott G. B. D. 1966; The isolation and partial characterisation of serum thrombotic accelerator (STA). British Journal of Experimental Pathology 47: 177.
• 12 Howell R. M, and Scott G. B. D. 1967; Activation of serum thrombotic accelerator (STA) by digitonin and saponin. Thrombosis et Diathesis Haemorrhagica 18: 375.
• 13 Lundblad R. L, and Davie E. W. 1965; The activation of Stuart factor (factor X) by activated antihemophilic factor (activated factor VIII). Biochemistry 4: 113.
• 14 Macfaelane R. G. 1964; An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 202: 498.
• 15 Maroolis J. 1961; The effect of colloidal silica on blood coagulation. Australian Journal of experimental Biology 39: 249.
• 16 Prydz H. 1964; Studies on Proconvertin (factor VII) IV. The adsorption on barium sulphate. Scandinavian Journal of Clinical and Laboratory Investigation 16: 409.
• 17 Skipski V. P, Peterson R. F, and Barclay M. 1962; Separation of phosphatidyl ethanolamine, phosphatidyl serine and other phospholipids by thin layer chromatography. Journal of Lipid Research 3: 467.